Scholl Hendrik Peter's Form 4 filing
Belite Bio, IncBLTE · filed Nov 16, 2026
- Accession no.
- 0001193125-26-464091
- Filed
- Nov 16, 2026, 7:13 PM ET
- Trade date
- Nov 12, 2026
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions. Open-market sales total $332.0K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Scholl Hendrik PeterCIK 0002113223 | Officer (Chief Medical Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 12, 2026 | American depositary share | SSaleDisposed | −500 | $162.04 | −$81,019.7 | 14,000 | Indirect | |
| Nov 12, 2026 | American depositary share | SSaleDisposed | −500 | $164.68 | −$82,341.95 | 13,500 | Indirect | |
| Nov 12, 2026 | American depositary share | SSaleDisposed | −500 | $166.82 | −$83,409.75 | 13,000 | Indirect | |
| Nov 12, 2026 | American depositary share | SSaleDisposed | −500 | $170.41 | −$85,204.7 | 12,500 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.